Kluwer Competition Law Blog
Innovation Competition in EU Merger Control: The Commission in Pursuit of a New Greater Good?
January 23, 2018
The European Commission’s recent focus on the impact of mergers on innovation competition has sparked a heated debate amongst lawyers and economists. Innovation seems to have become the new “Greater Good” the Commission is pursuing when reviewing mergers, whether in the pharmaceutical or medical device sectors, in pesticides, engineering, ICT or other technology-driven industries.
This article was originally published on Kluwer Competition Law Blog.
Contacts
Capabilities
Suggested News & Insights
UK Competition and Markets Authority Issues £4.2M Fine and Orders £760k of Refunds for Drip PricingApril 20, 2026Sidley Represents Orion Resource Partners in Combination of Sweetwater Royalties With Uranium RoyaltyApril 16, 2026Game Changer: What DOJ’s Antitrust Whistleblower Rewards Program Means for Corporate Compliance ProgramsApril 15, 2026Industrial Accelerator Act: A New Framework for EU (Sustainable) Industrial GrowthApril 9, 2026Sidley Helps Secure Appellate Victory for Princeton University in Ivy League Athletic Scholarships Antitrust Class ActionApril 6, 2026Sidley Represents Axsome Therapeutics in its Acquisition of Global Rights to Balipodect from TakedaApril 3, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
